7 Patents
- US125036962025Rnai Agents for Inhibiting Expression of Inhibin Subunit Beta E (INHBE), Pharmaceutical Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US124420022025Rnai Agents for Inhibiting Expression of Activin Receptor-like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US123785582025Rnai Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US120547182024Rnai Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US118459372023Rnai Agents for Inhibiting Expression of DUX4, Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US116293492023Rnai Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use
ARROWHEAD PHARMACEUTICALS, Inc.
0 cites - US115491122023Rnai Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use
ARROWHEAD PHARMACEUTICALS, Inc.
0 cites